Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Biofrontera Inc. Warrants
BFRIW | US
0.04
USD-0.00
-6.27%
BFRIW | US
About Biofrontera Inc. Warrants
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
17/04/2026
Close
0.04
Open
0.04
High
0.04
Low
0.03
Biofrontera Inc. a biopharmaceutical company develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn Massachusetts.
View LessBFRIW | US
Risk
245.4
Sharpe
-0.14
Luna's Score
49/100
Recommendation
Hold
Luna says (BFRIW | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
320.3%1 month
245.4%3 months
363.4%6 months
321.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
0.13
Debt to assets
0.07
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-18.32M
MarketCap
-
MarketCap(USD)
-
Div. yield
-
Op. margin
-64.69
Erngs. growth
-
Rev. growth
34.00
Ret. on equity
-149.41
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.04
Range1M
0.04
Range3M
0.04
Volumes: Market Activity
Rel. volume
1.42
Price X volume
426.55
